On June 15-16, the 3rd ZAODX World Cancer Early Screening Conference concluded in Xiong’an, Hebei. This conference is the largest event in the field of cancer early screening. Experts and entrepreneurs from many countries around the world attended the conference to discuss the development of cancer early screening.
At the same time, the third “Golden Cancer Screening Award” was held on June 16, with HymonBio winning the “Enterprise with High Potential” award.
This year’s “Golden Cancer Screening Award” selection was carried out in accordance with the principles of fairness, justice and openness. After strict scrutiny, the award list was officially announced at the meeting to encourage industry colleagues to continue to move forward firmly on the road of early cancer screening. HymonBio won the award for the most valuable company for investment with its innovative breakthrough technology products in the field of early cancer screening, as well as its hard-core corporate strength and breakthrough innovation advantages in the field of early cancer screening and early diagnosis. Also winning the award was Grail, a leading company in the field of early cancer detection, which HymonBio uses as a benchmark company. (In 2020, Grail was acquired by Illumina for US$8 billion, and its valuation soared rapidly in just a few years.)
This award is a recognition of HymonBio and has given us the motivation to continue moving forward. In the future, we will maintain scientific innovation, continuously upgrade and continue the field of early cancer screening products, and help more people prevent major diseases.
Post time: Jun-17-2024